Combined Immune Checkpoint Blockade and Helixor® Therapy in Oncology: Real-World Tolerability and Subgroup Survival (ESMO GROW)

ABSTRACT:

SUBMITTER: Thronicke A 

PROVIDER: S-EPMC12027740 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature